<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiotherapy, Balneology and Rehabilitation</journal-title><trans-title-group xml:lang="ru"><trans-title>Физиотерапия, бальнеология и реабилитация</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1681-3456</issn><issn publication-format="electronic">2413-2969</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">704161</article-id><article-id pub-id-type="doi">10.17816/rjpbr704161</article-id><article-id pub-id-type="edn">WYCOGR</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original studies</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The efficacy and safety repetitive transcranial magnetic stimulation in the treatment of migraine in children and adolescents: an open-label, single-arm, prospective, clinical trial</article-title><trans-title-group xml:lang="ru"><trans-title>Эффективность и безопасность ритмической транскраниальной магнитной стимуляции в терапии мигрени у детей и подростков: открытое проспективное несравнительное клиническое исследование</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>节律性经颅磁刺激治疗儿童及青少年偏头痛的有效性与安全性：开放式前瞻性无对照非随机临床研究</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7526-1553</contrib-id><contrib-id contrib-id-type="spin">2152-5737</contrib-id><name-alternatives><name xml:lang="en"><surname>Borodulina</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Бородулина</surname><given-names>Ирина Владимировна</given-names></name><name xml:lang="zh"><surname>Borodulina</surname><given-names>Irina V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine), Associate Professor</p></bio><bio xml:lang="ru"><p>канд. мед. наук, доцент</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine), Associate Professor</p></bio><email>irina.borodulina@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1741-7246</contrib-id><contrib-id contrib-id-type="spin">7625-6452</contrib-id><name-alternatives><name xml:lang="en"><surname>Gerasimenko</surname><given-names>Marina Yu.</given-names></name><name xml:lang="ru"><surname>Герасименко</surname><given-names>Марина Юрьевна</given-names></name><name xml:lang="zh"><surname>Gerasimenko</surname><given-names>Marina Yu.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><bio xml:lang="zh"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><email>mgerasimenko@list.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5188-3796</contrib-id><contrib-id contrib-id-type="spin">8300-9342</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>Светлана Викторовна</given-names></name><name xml:lang="zh"><surname>Pavlova</surname><given-names>Svetlana V.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Medicine)</p></bio><bio xml:lang="ru"><p>канд. мед. наук</p></bio><bio xml:lang="zh"><p>MD, Cand. Sci. (Medicine)</p></bio><email>pavlovasv@zdrav.mos.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного последипломного образования</institution></aff><aff><institution xml:lang="zh">Russian Medical Academy of Continuous Professional Education</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Children’s City Polyclinic No. 39, Moscow</institution></aff><aff><institution xml:lang="ru">Детская городская поликлиника № 39, Москва</institution></aff><aff><institution xml:lang="zh">Children’s City Polyclinic No. 39, Moscow</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Pirogov Russian National Research Medical University</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет им. Н.И. Пирогова</institution></aff><aff><institution xml:lang="zh">Pirogov Russian National Research Medical University</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-07-08" publication-format="electronic"><day>08</day><month>07</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-08-14" publication-format="electronic"><day>14</day><month>08</month><year>2026</year></pub-date><volume>25</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>224</fpage><lpage>235</lpage><history><date date-type="received" iso-8601-date="2026-03-12"><day>12</day><month>03</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-05-06"><day>06</day><month>05</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2026, Eco-Vector</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><copyright-holder xml:lang="zh">Eco-Vector</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2029-06-30"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://rjpbr.com/1681-3456/article/view/704161">https://rjpbr.com/1681-3456/article/view/704161</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> The article presents the results of a clinical study of repetitive transcranial magnetic stimulation (rTMS) in children with migraine.</p> <p><bold>AIM</bold><bold>:</bold> To evaluate the efficacy and safety of rTMS in children with migraine.</p> <p><bold>METHODS</bold>: A open-label, single-arm, prospective cohort clinical study was conducted in 41 pediatric patients with migraine (mean age 12.34 ± 3.42 years) at Children’s City Polyclinic No. 39 in Moscow. In stage 1, we used rTMS of the left primary motor cortex at 70% of the motor threshold, 10 Hz (6-sec train, 45-sec inter-train interval), 600 stimuli per session, 3 sessions. If efficacy parameters were not achieved within one month (≥50% reduction in pain intensity and/or ≥30% reduction in the number of monthly headache episodes), patients were transferred to stage 2 with the following parameters: 10 daily sessions (excluding weekends) , 10 Hz, 70% of the motor threshold, 4-sec train, 11-sec inter-train interval , and 3000 stimuli per session. Efficacy was assessed based on changes in headache diary parameters, questionnaire scores, and instrumental findings.</p> <p><bold>RESULTS:</bold> In stage 1, 21.9% of patients achieved the efficacy criteria. In stage 2, positive changes were observed in headache intensity and frequency (<italic>p</italic> &lt; 0.001): 28% of patients had a ≥50% reduction in pain intensity; 100% of patients had a ≥30% reduction in headache frequency. The HADS depression subscale score decreased by 41.7% (<italic>p</italic> &lt; 0.001); the Spielberger–Hanin anxiety scale score decreased by 5.8 points for trait anxiety and by 7.6 points for state anxiety (<italic>p</italic> &lt; 0.001); positive changes were observed on the CPAQ-R (5.2%, <italic>p</italic><italic> </italic>= 0.003), and PedsQL (11.9%, <italic>p</italic> &lt; 0.001).</p> <p><bold>CONCLUSION:</bold> rTMS of the left primary motor cortex significantly reduces the number of episodes and intensity of migraine headaches in children, reduces symptoms of anxiety and depression, positively affects quality of life and functional nervous system parameters, and is characterized by a favorable safety profile and good tolerability. Increasing the number of stimuli and sessions improves efficacy and increases the proportion of patients with a successful outcome.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Статья посвящена результатам клинического исследования ритмической транскраниальной магнитной стимуляции у детей с мигренью.</p> <p><bold>Цель исследования.</bold> Оценить эффективность и безопасность применения ритмической транскраниальной магнитной стимуляции у детей с мигренью.</p> <p><bold>Методы.</bold> Выполнено проспективное открытое когортное несравнительное клиническое исследование 41 пациента детского возраста с мигренью на базе Детской городской поликлиники № 39 г. Москвы (средний возраст — 12,34±3,42 года). На первом этапе применяли ритмическую стимуляцию левой моторной коры с мощностью 70% от порога вызванного моторного ответа, частотой 10 Гц (6 секунд посылка, 45 секунд пауза), всего 600 импульсов; на курс 3 процедуры. При недостижении показателей эффективности в течение месяца (снижение интенсивности боли на 50% и более; снижение количества эпизодов боли в месяц на 30% и более) пациентов переводили на второй этап исследования с применением следующих параметров: 10 ежедневных процедур (за исключением выходных дней), 10 Гц, интенсивность 70% от порога вызванного моторного ответа; 4 секунды посылка, 11 секунд пауза; на процедуру 3000 импульсов. Оценка эффективности основывалась на динамике параметров дневника головной боли, опросников, инструментальных исследований.</p> <p><bold>Результаты</bold>. После первого этапа достижение параметров эффективности наблюдалось у 21,9% пациентов. На втором этапе отмечалась положительная динамика по интенсивности и частоте эпизодов головной боли (<italic>p</italic> &lt;0,001). Доля пациентов со снижением интенсивности боли на 50% и более составила 28%; со снижением количества эпизодов головной боли на 30% и более — 100%. Динамика среднего балла по подшкале депрессии HADS составила 41,7% (<italic>p</italic> &lt;0,001); по шкале Спилбергера–Ханина отмечалось снижение на 5,8 пункта личностной и 7,6 ситуативной тревожности (<italic>p</italic> &lt;0,001); наблюдалась положительная динамика по опросникам CPAQ-R — на 5,2% (<italic>p</italic>=0,003) и качества жизни PedsQL — на 11,9% (<italic>p</italic> &lt;0,001).</p> <p><bold>Заключение.</bold> Ритмическая транскраниальная магнитная стимуляция левой моторной коры значимо снижает количество эпизодов и интенсивность головной боли при мигрени у детей, уменьшает симптомы тревоги и депрессии, положительно влияет на качество жизни и функциональные показатели нервной системы, характеризуется безопасностью, хорошей переносимостью. Увеличение количества стимулов и процедур повышает эффективность и долю пациентов с успешным исходом.</p></trans-abstract><trans-abstract xml:lang="zh"><p>背景。本文报道了节律性经颅磁刺激治疗儿童偏头痛的临床研究结果。</p> <p>目的。评估节律性经颅磁刺激治疗儿童偏头痛的有效性与安全性。</p> <p>方法。在莫斯科市第39儿童综合门诊部开展开放式前瞻性队列无对照非随机临床研究，纳入41名偏头痛患儿（平均年龄12.34±3.42岁）。第一阶段采用左运动皮层节律性刺激方案：强度为诱发运动阈值的70%，频率10Hz（6秒刺激，45秒间歇），单次600个脉冲，共3次治疗。若一个月内未达到有效参数（疼痛强度降低≥50%；每月发作次数减少≥30%），则转入第二阶段治疗：每日1次（周末除外），10Hz频率，70%运动阈值强度；4秒刺激，11秒间歇；单次3000个脉冲。疗效评估基于头痛日记参数动态变化、量表问卷及仪器检查结果。</p> <p>结果。第一阶段治疗后21.9%患者达到有效参数。第二阶段显示头痛强度与发作频率均呈积极改善（<italic>p</italic>&lt;0.001）。疼痛强度降低≥50%者占28%；头痛发作次数减少≥30%者达100%。HADS抑郁分量表平均分改善41.7%（<italic>p</italic>&lt;0.001）；Spielberger-Hanin量表中特质焦虑降低5.8分、状态焦虑降低7.6分（<italic>p</italic>&lt;0.001）；CPAQ-R问卷改善5.2%（<italic>p</italic>=0.003）；PedsQL生活质量量表改善11.9%（<italic>p</italic>&lt;0.001）。</p> <p>结论。左运动皮层节律性经颅磁刺激可显著降低儿童偏头痛发作频率与强度，减轻焦虑抑郁症状，积极影响生活质量及神经系统功能指标，具有安全性好、耐受性佳的特点。增加刺激次数与治疗频次可提升疗效及治疗成功率。</p></trans-abstract><kwd-group xml:lang="en"><kwd>migraine</kwd><kwd>chronic pain</kwd><kwd>repetitive transcranial magnetic stimulation</kwd><kwd>rehabilitation</kwd><kwd>children</kwd><kwd>adolescents</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мигрень</kwd><kwd>хроническая боль</kwd><kwd>ритмическая транскраниальная магнитная стимуляция</kwd><kwd>реабилитация</kwd><kwd>дети</kwd><kwd>подростки</kwd></kwd-group><kwd-group xml:lang="zh"><kwd>偏头痛</kwd><kwd>慢性疼痛</kwd><kwd>节律性经颅磁刺激</kwd><kwd>康复</kwd><kwd>儿童</kwd><kwd>青少年</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Sundblad G, Saartok T, Engström L. Prevalence and co-occurrence of selfrated pain and perceived health in school children: аge and gender differences. European Journal of Pain. 2007;11(2):171–180. doi: 10.1016/j.ejpain.2006.02.006</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sergeev AV, Ekusheva EV. Migraine in children. Diagnostics features and modern possibilities of therapy. RMJ. Medical Review. 2018;2(9):28–32 (In Russ.) EDN: YQJOIH</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Abu-Arafeh I, Morozova M. Migraine in children and adolescents: Assessment and diagnosis. Handb Clin Neurol. 2024;199:475–485. doi: 10.1016/B978-0-12-823357-3.00029-X</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia. 2010;30(9):1065–72. doi: 10.1177/0333102409355601</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Azimova YuE, Amelin AV, Alferova VV, et al. Clinical guidelines “Migraine”. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(1–3):4–36. doi: 10.17116/jnevro20221220134 EDN: HHGQYC</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1–211.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Khan J, Asoom LIA, Sunni AA, et al. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021;139:111557. doi: 10.1016/j.biopha.2021.111557</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Berdnikova AV, Kadymova NB, Latysheva NV, Filatova EG. Impact of anti-CGRP monoclonal antibodies on central sensitization level in migraine patients. Medical alphabet. 2023;(33):6–12. doi: 10.33667/2078-5631-2023-33-8-12 EDN: GNHIPW</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Lee LH, Olness KN. Clinical and demographic characteristics of migraine in urban children. Headache. 1997;37(5):269–76. doi: 10.1046/j.1526-4610.1997.3705269.x</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Arruda MA, Arruda R, Guidetti V, Bigal ME. Psychosocial adjustment of children with migraine and tension-type headache — a nationwide study. Headache. 2015;55(Suppl 1):39–50. doi: 10.1111/head.12510</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Izmaylova IG, Belopasov VV, Jumagaziev AA, Kostina LA. Prediction of chronic migraine in children and adolescents. Russian journal of pain. 2015;40(3–4):22–27. EDN: YLOYSN</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Lefaucheur JP, Aleman A, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clin Neurophysiol. 2020;131(2):474–528. doi: 10.1016/j.clinph.2019.11.002</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Tsai YY, Wu WT, Han DS, Mezian K, et al. Application of Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain: A Narrative Review. Life (Basel). 2023;13(2):258. doi: 10.3390/life13020258</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Borodulina IV, Badalov NG, Gushcha AO, Rachin A.P. Non-pharmacological technologies of medical rehabilitation in the treatment of patients with radicular pain syndrome. Russian journal of pain. 2018;2(56):248 (In Russ.) EDN: XODUZF</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hosomi K, Kishima H, Oshino S, et al. Cortical excitability changes after high-frequency repetitive transcranial magnetic stimulation for central poststroke pain. Pain. 2013;154(8):1352–7. doi: 10.1016/j.pain.2013.04.017</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kotova OV, Borodulina IV. Pain in children and adolescents. Clinical review for general practice. 2024;5(8):79–83. doi: 10.47407/kr2024.5.8.00463</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Fernandes AM, Graven-Nielsen T, de Andrade DC. New updates on transcranial magnetic stimulation in chronic pain. Curr Opin Support Palliat Care. 2022;16(2):65–70. doi: 10.1097/SPC.0000000000000591</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Leung A, Shirvalkar P, Chen R, Kuluva J, et al.; Expert Consensus Panel. Transcranial Magnetic Stimulation for Pain, Headache, and Comorbid Depression: INS-NANS Expert Consensus Panel Review and Recommendation. Neuromodulation. 2020;23(3):267–290. doi: 10.1111/ner.13094</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Zhong J, Lan W, Feng Y, Yu L, et al. Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: A meta-analysis. Front Neurol. 2022;13:1050090. doi: 10.3389/fneur.2022.1050090</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Saltychev M, Juhola J. Effectiveness of High-Frequency Repetitive Transcranial Magnetic Stimulation in Migraine: A Systematic Review and Meta-analysis. Am J Phys Med Rehabil. 2022;101(11):1001–1006. doi: 10.1097/PHM.0000000000001953</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Calabrò RS, Billeri L, Manuli A, Iacono A, Naro A. Applications of transcranial magnetic stimulation in migraine: evidence from a scoping review. J Integr Neurosci. 2022;21(4):110. doi: 10.31083/j.jin2104110</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hansen JM, Baca SM, Vanvalkenburgh P, Charles A. Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording. Brain. 2013;136(Pt 12):3589–95. doi: 10.1093/brain/awt309</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Andreou AP, Holland PR, Akerman S, et al. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain. 2016;139(Pt 7):2002–14. doi: 10.1093/brain/aww118</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Zardouz S, Shi L, Leung A. A feasible repetitive transcranial magnetic stimulation clinical protocol in migraine prevention. SAGE Open Med Case Rep. 2016;4:2050313X16675257. doi: 10.1177/2050313X16675257</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Borodulina IV, Gerasimenko MYu, Kotova OV, Pavlova SV, Zaytseva T.N. Repetitive Transcranial Magnetic Stimulation in the Treatment of Tension-Type Headache in Children and Adolescents: An Open-Label Prospective Clinical Study. Bulletin of Rehabilitation Medicine. 2026;25(1):40–52. doi: 10.38025/2078-1962-2026-25-1-40-52 EDN: FJUNMR</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Kalita J, Laskar S, Bhoi SK, Misra UK. Efficacy of single versus three sessions of high rate repetitive transcranial magnetic stimulation in chronic migraine and tension-type headache. J Neurol. 2016;263(11):2238–2246. doi: 10.1007/s00415-016-8257-2</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Varni JW, Thompson KL, Hanson V. The Varni/Thompson Pediatric Pain Questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis. Pain. 1987;28(1):27–38. doi: 10.1016/0304-3959(87)91056-6</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Denisova RV, Alekseyeva YeI, Al’bitskiy VYu, et al. Reliability, validity and sensitivity of russian versions of PedsQL Generic Core Scale and PedsQL Rheumatology Module Questionnaires. Current pediatrics (Moscow). 2009;8(1):30–40. doi: 10.1016/j.jpedsurg.2005.11.006 EDN: KGBOBR</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>McCracken LM, Vowles KE, Eccleston C. Acceptance of chronic pain: component analysis and a revised assessment method. Pain. 2004;107(1–2):159–66. doi: 10.1016/j.pain.2003.10.012</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Mantrova IN. Methodological Guide on Psychophysiological and Psychological Diagnostics. Ivanovo; 2007. 216 p. (In Russ.)</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Akimova MK, Kozlova VT. Recommendations for Using the Results of Diagnostics of Natural Human Characteristics in Pedagogical Practice. Methods of Diagnostics of Natural Human Psychophysiological Characteristics. Moscow; 1992. Vol. 2: 99–110. (In Russ.)</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ilyin EP, editor. Psychomotor Organization of a Human Being: Textbook for Universities. St. Petersburg: Peter; 2003. (In Russ.)</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Budukool LKC, Khovalygh AM, Sarygh SKO. Neurodynamic indicators by tapping-test of students of Tuvan state university. Vestnik Hakasskogo gosudarstvennogo universiteta im. N.F. Katanova. 2013;(6):16–19. (In Russ.) EDN: SGMGCZ</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Spielberger CD. Test Anxiety Inventory: Preliminary professional manual. Menlo Park; 1980.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Hanin YuL. Adaptation of Yu.L. Hanin’s method. A brief guide to the Spielberger’s scale of reactive and personal anxiety. Leningrad; 1976. 18 p. (In Russ.)</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Bakulin IS, Poydasheva AG, Lagoda DYu, et al. Safety and tolerability of different protocols of high-frequency rhythmic transcranial magnetic stimulation. Ulyanovsk medico-biological journal. 2019;(1):26–37. doi: 10.34014/ 2227-1848-2019-1-26-37 EDN: ZDFDKH</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sereda AP, Andrianova MA. Study Design Guidelines. Traumatology and orthopedics of Russia. 2019;25(3):165–184. doi: 10.21823/2311-2905-2019-25-3-165-184</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. TROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335:806–808. doi: 10.1136/bmj.39335.541782.AD</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>O’Reardon JP, Fontecha JF, Cristancho MA, Newman S. Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: a report of two cases. CNS Spectr. 2007;12(12):921–5. doi: 10.1017/s1092852900015716</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Allen CH, Kluger BM, Buard I. Safety of Transcranial Magnetic Stimulation in Children: A Systematic Review of the Literature. Pediatr Neurol. 2017;68:3–17. doi: 10.1016/j.pediatrneurol.2016.12.009</mixed-citation></ref></ref-list></back></article>
